Cargando…

Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure

Liver failure is a severe clinical syndrome with high mortality. 5-Hydroxytryptamine 3 receptor antagonists (5-HT3RAs) can reduce liver damage in animal models. We investigated whether 5-HT3RAs may improve the prognosis of liver failure. We analyzed the 28 and 90 days mortality of liver failure pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuting, Sun, Jingkang, Fan, Xiude, Wang, Xiaoyun, Zeng, Lu, Zhang, Xiaoge, Zhang, Kun, Li, Na, Han, Qunying, Liu, Zhengwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100675/ https://www.ncbi.nlm.nih.gov/pubmed/33967787 http://dx.doi.org/10.3389/fphar.2021.648736

Ejemplares similares

Alterations in circadian rhythms aggravate Acetaminophen-induced liver injury in mice by influencing Acetaminophen metabolization and increasing intestinal permeability
por: Zhang, Kun, et al.
Publicado: (2022)

Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Han, Qunying, et al.
Publicado: (2021)

Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma
por: Zeng, Lu, et al.
Publicado: (2020)

Association of LIN28B polymorphisms with chronic hepatitis B virus infection
por: Han, Qunying, et al.
Publicado: (2020)

Bioinformatics Analysis based on Multiple Databases Identifies Hub Genes Associated with Hepatocellular Carcinoma
por: Zeng, Lu, et al.
Publicado: (2019)

Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection
por: Deng, Huan, et al.
Publicado: (2020)

High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world setting
por: Han, Qunying, et al.
Publicado: (2019)

High Serum Procalcitonin Concentrations in Patients With Hemorrhagic Fever With Renal Syndrome Caused by Hantaan Virus
por: Fan, Xiude, et al.
Publicado: (2018)

Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection
por: Li, Fang, et al.
Publicado: (2018)

Association of polymorphism rs1053005 in STAT3 with chronic hepatitis B virus infection in Han Chinese population
por: Li, Man, et al.
Publicado: (2018)

Platelet Distribution Width at First Day of Hospital Admission in Patients with Hemorrhagic Fever with Renal Syndrome Caused by Hantaan Virus May Predict Disease Severity and Critical Patients' Survival
por: Fan, Xiude, et al.
Publicado: (2018)

A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels
por: Chen, Yanping, et al.
Publicado: (2018)

The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.
por: Bermudez, J., et al.
Publicado: (1988)

Effective treatment with combination of peripheral 5‐hydroxytryptamine synthetic inhibitor and 5‐hydroxytryptamine 2 receptor antagonist on glucocorticoid‐induced whole‐body insulin resistance with hyperglycemia
por: Ma, Shaoxin, et al.
Publicado: (2016)

The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
por: Palli, Swetha Rao, et al.
Publicado: (2015)

Vasomotor Effects of Acetylcholine, Bradykinin, Noradrenaline, 5-Hydroxytryptamine, Histamine and Angiotensin II on the Mouse Basilar Artery
por: ISLAM, Md. Zahorul, et al.
Publicado: (2014)

The Effect of 5-Hydroxytryptamine Receptor Antagonist in Preventing Pain/Limb Shrinkage Reaction Associated with Rocuronium Injection
por: He, Qixiong, et al.
Publicado: (2018)

5- Hydroxytryptamine
por: Giarman, Nicholas J.
Publicado: (1958)

Vasomotor effects of 5-hydroxytryptamine, histamine, angiotensin II, acetylcholine, noradrenaline, and bradykinin on the cerebral artery of bottlenose dolphin (Tursiops truncatus)
por: ISLAM, Md. Zahorul, et al.
Publicado: (2020)

Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
por: Arai, Toru, et al.
Publicado: (2022)

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
por: Pozhidaev, Ivan V., et al.
Publicado: (2020)

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
por: Liu, Zhi-Mei, et al.
Publicado: (2022)

Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer
por: Zhan, Dandan, et al.
Publicado: (2023)

Opportunities and perspectives for developing orexin receptor antagonists
por: Steiner, Michel A., et al.
Publicado: (2014)

Orexin receptor antagonists as therapeutic agents for insomnia
por: Equihua, Ana C., et al.
Publicado: (2013)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2021)

5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials
por: Pithadia, Anand B., et al.
Publicado: (2009)

External Validation of a Nomogram and Risk Grouping System for Predicting Individual Prognosis of Patients With Medulloblastoma
por: Guo, Chengcheng, et al.
Publicado: (2020)

Serotonin in the rat prefrontal cortex controls the micturition reflex through 5‐hydroxytryptamine 2A and 5‐hydroxytryptamine 7 receptors
por: Chiba, Hiroki, et al.
Publicado: (2020)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011)

Orexin, orexin receptor antagonists and central cardiovascular control
por: Carrive, Pascal
Publicado: (2013)

Pharmacodynamics of the Glutamate Receptor Antagonists in the Rat Barrel Cortex
por: Vinokurova, Daria, et al.
Publicado: (2018)

Novel Treatment of Ventilator Dyssynchrony From Central Alveolar Hypoventilation Syndrome Utilizing Scheduled 5-Hydroxytryptamine-3 Receptor Antagonist
por: Malkoc, Aldin, et al.
Publicado: (2022)

Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma
por: Portnoy, Alison, et al.
Publicado: (2013)

Multiple Targeting Approaches on Histamine H(3) Receptor Antagonists
por: Khanfar, Mohammad A., et al.
Publicado: (2016)

STORAGE OF 5-HYDROXYTRYPTAMINE IN MEGAKARYOCYTES
por: Tranzer, J. P., et al.
Publicado: (1972)

Comparative effectiveness of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: a network meta-analysis of randomized controlled studies
por: Rokkas, Theodore, et al.
Publicado: (2021)

Association of Mineralocorticoid Receptor Antagonists With the Mortality and Cardiovascular Effects in Dialysis Patients: A Meta-analysis
por: Gou, Wen-Jun, et al.
Publicado: (2022)

Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study
por: Zhang, Xue-Sha, et al.
Publicado: (2023)

Histamine H3 Receptor Antagonist Enhances Neurogenesis and Improves Chronic Cerebral Hypoperfusion-Induced Cognitive Impairments
por: Wang, Na, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fbkjigdji1bg3ucqb5k7m3vcu1